TrialBritish journal of clinical pharmacology2009

Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite.

Bharat D Damle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.